Zydus Lifesciences FY 24 net profit jumps 97%
India Business News: AHMEDABAD: Homegrown pharma major, Zydus Lifesciences Limited on Friday posted a 97% jump in its consolidated net profit which stood at Rs 3,859.
Stay updated with breaking news from Zydus Lifescience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India Business News: AHMEDABAD: Homegrown pharma major, Zydus Lifesciences Limited on Friday posted a 97% jump in its consolidated net profit which stood at Rs 3,859.
Incred Equities estimates Mirabegron to be a $75-80 million opportunity for Zydus Lifesciences, as the company also enjoys a 180-day exclusivity period
When a trader is expecting the stock prices to fall, he may sell the stock without owning that and buy at a lower price, for example, stock XYZ is trading at 100, a trader sells the stocks at Rs 100 and buys it back at Rs 90. He made a profit of Rs 10. Selling the stocks without owing the underlying stock is called short selling.
The business would work together with the USFDA to resolve the concerns, it announced.
Linde India has seen a nice breakout of downward sloping resistance trendline adjoining highs of October 12, 2023 and February 19, 2024. The stock formed long bullish candlestick pattern on the daily charts with above average volumes.